Tyrosine Kinase Receptors Stocks List

Recent Signals

Date Stock Signal Type
2021-02-26 BBIO MACD Bullish Signal Line Cross Bullish
2021-02-26 BBIO Pocket Pivot Bullish Swing Setup
2021-02-26 BBIO Expansion Pivot Buy Setup Bullish Swing Setup
2021-02-26 BBIO 180 Bullish Setup Bullish Swing Setup
2021-02-26 BBIO 20 DMA Support Bullish
2021-02-26 BBIO Crossed Above 50 DMA Bullish
2021-02-26 BDTX 20 DMA Support Bullish
2021-02-26 BPMC 20 DMA Resistance Bearish
2021-02-26 BPMC Pocket Pivot Bullish Swing Setup
2021-02-26 DCPH Slingshot Bearish Bearish Swing Setup
2021-02-26 FPRX Slingshot Bullish Bullish Swing Setup
2021-02-26 FUSN Lizard Bullish Bullish Day Trade Setup
2021-02-26 FUSN Fell Below 20 DMA Bearish
2021-02-26 FUSN Hammer Candlestick Bullish
2021-02-26 FUSN Doji - Bullish? Reversal
2021-02-26 MACK MACD Bearish Centerline Cross Bearish
2021-02-26 MACK 1,2,3 Pullback Bullish Bullish Swing Setup
2021-02-26 PBYI 200 DMA Resistance Bearish
2021-02-26 PBYI Expansion Breakdown Bearish Swing Setup
2021-02-26 PBYI Lower Bollinger Band Walk Weakness
2021-02-26 ZNTL Stochastic Reached Overbought Strength
2021-02-26 ZNTL Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2021-02-26 ZNTL Crossed Above 200 DMA Bullish

Recent News for Tyrosine Kinase Receptors Stocks

Date Stock Title
Feb 28 BBIO BridgeBio Pharma and Affiliate Origin Biosciences Announce FDA Approval of NULIBRY™ (fosdenopterin), the First and Only Approved Therapy to Reduce the Risk of Mortality in Patients with MoCD Type A
Feb 27 VOR The Week Ahead In Biotech (Feb. 28-March 6): KemPharm, Gilead FDA Decisions and More Earnings
Feb 27 BPMC 15 Fastest Growing Biotech Companies in the US
Feb 27 RLAY Relay Therapeutics: A Long-Term Position In Data-Driven Drug Developer Looks Attractive
Feb 26 FPRX Five Prime Therapeutics to Participate in the Cowen 41st Annual Health Care Conference
Feb 26 PBYI Puma (PBYI) Q4 Loss Wider Than Expected, Nerlynx Sales Fall
Feb 26 PBYI Puma Biotechnology and CANbridge terminate NERLYNX license agreement
Feb 26 BBIO Is a Surprise Coming for BridgeBio Pharma (BBIO) This Earnings Season?
Feb 26 PBYI The Daily Biotech Pulse: Adcom Test Awaits J&J's COVID-19 Vaccine, Lilly To Supply Additional Antibody Therapy Doses To US, Regulatory Setback For Tricida
Feb 26 PBYI Puma Biotechnology's (PBYI) CEO Alan Auerbach on Q4 2020 Results - Earnings Call Transcript
Feb 25 PBYI Puma Biotechnology EPS misses by $0.05, misses on revenue
Feb 25 PBYI Puma Biotechnology and Pierre Fabre amend NERLYNX license agreement
Feb 25 PBYI Puma Biotechnology and Pierre Fabre Amend NERLYNX® License Agreement to Include Greater China
Feb 25 PBYI Puma Biotechnology Reports Fourth Quarter and Full Year Financial Results
Feb 25 BBIO BridgeBio Pharma EPS misses by $0.16, misses on revenue
Feb 25 BBIO BridgeBio Pharma, Inc. Reports Fourth Quarter And Full Year 2020 Financial Results And Business Update
Feb 25 ZNTL Zentalis and Tempus ink research collaboration deal
Feb 25 ZNTL Zentalis Pharmaceuticals and Tempus Announce Strategic Collaboration to Advance Research and Development Capabilities
Feb 24 PBYI Puma Biotechnology Q4 2020 Earnings Preview
Feb 24 BBIO BridgeBio Pharma To Announce Proof-Of-Concept Data from ADH1 at the Endocrine Society’s 2021 Annual Meeting
Related Industries: Biotechnology